We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-12.76%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$595M
AUM Growth
-$43.1M
Cap. Flow
+$44.1M
Cap. Flow %
7.42%
Top 10 Hldgs %
60.6%
Holding
37
New
6
Increased
11
Reduced
12
Closed
4

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$21.9M
2
CVS icon
CVS Health
CVS
+$19.9M
3
CELG
Celgene Corp
CELG
+$19.4M
4
QGEN icon
Qiagen
QGEN
+$14.3M
5
AGN
Allergan plc
AGN
+$11.5M

Top Sells

Rank Stock Value
1
IART icon
Integra LifeSciences
IART
+$22.3M
2
MRK icon
Merck
MRK
+$20M
3
BAX icon
Baxter International
BAX
+$14.6M
4
SHPG
Shire pic
SHPG
+$13.9M
5
AZN icon
AstraZeneca
AZN
+$7.24M

Sector Composition

Rank Sector Weight
1 Healthcare 99.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABT icon
1
Abbott
ABT
$175B
$64.9M 10.91%
897,276
-85,036
-9% -$5.98M
BMY icon
2
Bristol-Myers Squibb
BMY
$124B
$58.7M 9.86%
1,128,470
+407,590
+57% +$21.9M
BSX icon
3
Boston Scientific
BSX
$65.4B
$46.2M 7.77%
1,308,374
-75,000
-5% -$2.72M
MRK icon
4
Merck
MRK
$315B
$35.2M 5.92%
483,176
-282,960
-37% -$20M
BAX icon
5
Baxter International
BAX
$11.7B
$32.2M 5.42%
489,628
-216,600
-31% -$14.6M
RVTY icon
6
Revvity
RVTY
$12.3B
$28.2M 4.74%
359,081
-10,000
-3% -$845K
GILD icon
7
Gilead Sciences
GILD
$167B
$27.2M 4.57%
434,357
+111,170
+34% +$7.77M
NUVA
8
DELISTED
NuVasive, Inc.
NUVA
$23.5M 3.95%
473,923
+78,700
+20% +$4.73M
BIO icon
9
Bio-Rad Laboratories Class A
BIO
$8.15B
$22.5M 3.78%
96,697
– –
SHPG
10
DELISTED
Shire pic
SHPG
$21.9M 3.68%
125,656
-79,600
-39% -$13.9M
INCY icon
11
Incyte
INCY
$23.4B
$21.4M 3.6%
336,444
+122,680
+57% +$7.97M
A icon
12
Agilent Technologies
A
$37.1B
$21.3M 3.57%
315,051
+101,751
+48% +$6.85M
IONS icon
13
Ionis Pharmaceuticals
IONS
$8.99B
$20.5M 3.45%
379,421
+176,987
+87% +$9.03M
ELV icon
14
Elevance Health
ELV
$80.9B
$19.3M 3.25%
73,513
-10,000
-12% -$2.75M
CVS icon
15
CVS Health
CVS
$137B
$17.5M 2.94%
+266,670
New +$19.9M
CELG
16
DELISTED
Celgene Corp
CELG
$16.9M 2.83%
+263,000
New +$19.4M
QGEN icon
17
Qiagen
QGEN
$8.49B
$14M 2.36%
+384,206
New +$14.3M
PRGO icon
18
Perrigo
PRGO
$1.48B
$11.9M 2%
306,820
-6,400
-2% -$406K
BIIB icon
19
Biogen
BIIB
$30.4B
$9.96M 1.67%
33,100
-2,900
-8% -$925K
PDCO
20
DELISTED
Patterson Companies, Inc.
PDCO
$9.48M 1.59%
482,263
+4,556
+1% +$106K
AGN
21
DELISTED
Allergan plc
AGN
$9.36M 1.57%
+70,000
New +$11.5M
CAH icon
22
Cardinal Health
CAH
$53.5B
$9.2M 1.55%
206,335
+70,000
+51% +$3.65M
UHS icon
23
Universal Health Services
UHS
$9.15B
$9.08M 1.53%
77,906
-27,106
-26% -$3.41M
RDY icon
24
Dr. Reddy's Laboratories
RDY
$10.5B
$6.46M 1.09%
856,095
– –
MCK icon
25
McKesson
MCK
$98.5B
$6.24M 1.05%
+56,500
New +$7.05M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q4 2018 Portfolio in Review

As of Q4 2018, Sector Gamma AS held 37 positions worth $595M, down 6.8% from $638M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Sector Gamma AS deployed $44.1M of net new capital in Q4 2018, opening 6 new positions and adding to 11 existing holdings. Its largest new stake was CVS Health: 266,670 shares worth $17.5M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier.

On the sell side, the largest reduction was Merck, an estimated $20M trimmed.

  • Sector Gamma AS's largest Q4 2018 buy was CVS Health: 266,670 shares worth $17.5M.
  • Sector Gamma AS added most to Bristol-Myers Squibb in Q4 2018, an estimated $21.9M increase.
  • Sector Gamma AS's biggest Q4 2018 reduction was Merck, cutting an estimated $20M.
  • Sector Gamma AS fully exited Integra LifeSciences in Q4 2018, selling an estimated $22.3M.
  • Sector Gamma AS's ten largest holdings make up 61% of its $595M portfolio in Q4 2018.
  • Sector Gamma AS opened 6 new positions and closed 4 in Q4 2018.
  • Sector Gamma AS's portfolio value fell 6.8% quarter-over-quarter to $595M.

Based on Sector Gamma AS's 13F filing for Q4 2018, filed 12 Feb 2019.